Global “Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market” 2025 report by |89 Pages| delivers a comprehensive market analysis utilizing various analytical frameworks, such as Porter’s Five Forces Analysis and PESTEL Analysis. These methodologies offer a detailed evaluation of both micro- and macro-environmental factors impacting market growth during the forecast period. The goal is to significantly increase market share by 2032 through these strategies, with revenue segmented by type and a projected market size by application. .

Overview of the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Report:

According to our latest analysis, the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size was valued at USD 1428.3 million in 2023 and is forecast to a readjusted size of USD 2826.1 million by 2030 with a CAGR of 10.2% during review period.

Irritable bowel syndrome (IBS) is a common disorder that affects the large intestine. Signs and symptoms include cramping, abdominal pain, bloating, gas, and diarrhea or constipation, or both. IBS is a chronic condition that need to manage long term.

IBS that causes increased diarrhea is often called IBS-D. Diarrhea predominant irritable bowel syndrome (IBS-D) is a subtype of IBS in which a person experiences frequent episodes of diarrhea with accompanying abdominal pain. Like IBS, IBS-D is a functional gastrointestinal disorder (FGD) in that there is no visible disease, inflammation, or injury to account for its symptoms. It is estimated that approximately a third of people who have IBS experience the disorder with diarrhea as the predominant bowel habit.

In this report, we study the drugs for diarrhea predominant irritable bowel syndrome (IBS-D).

North America is the largest consumption place of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs, followed by Europe. The two account for more than 80% of the consumer market in together. The most used IBS-D drug is XIFAXAN, accounting for more than 60% of the market share, followed by Viberzi and Lotronex. IBS-D drugs are widely sold through hospital pharmacies and retail pharmacies.

The Global Info Research report includes an overview of the development of the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs industry chain, the market status of Hospitals Pharmacy (XIFAXAN, Viberzi), Retail Pharmacy (XIFAXAN, Viberzi), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs.

Regionally, the report analyzes the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market, with robust domestic demand, supportive policies, and a strong manufacturing base.

Who is the Top global Manufacturer in the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market?

  • Bausch Health
  • Allergan
  • Sebela Pharmaceuticals
  • Astellas Pharmaceuticals
  • Amneal Pharms
  • Pharscin Pharma

Inquire more and share questions if any before the purchase on this report at:https://www.marketreportsworld.com/enquiry/pre-order-enquiry/26323168

Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Forecast by regions, type and application, with sales and revenue, from 2025 to 2032. Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Share, distributors, major suppliers, changing price patterns and the supply chain of raw materials is highlighted in the report.Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size report provides important information regarding the total valuation that this industry holds presently and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.This Report Focuses on the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market manufacturers, to study the sales, value, market share and development plans in the future. It is Define, describe and forecast the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Growth by type, application, and region to Study the global and key regions market potential and advantage, opportunity and challenge, restraints and risks. Know significant trends and factors driving or inhibiting the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market growth opportunities in the market for stakeholders by identifying the high growth segments. Strategically it examines each submarket with respect to individual growth trend and their contribution to the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market.

What are the major type and applications, of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs?

What are the types of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs available in the Market?

  • XIFAXAN
  • Viberzi
  • Lotronex
  • Other
  • Market segment by Sales Channel
  • Hospitals Pharmacy
  • Retail Pharmacy
  • Other
  • Major players covered
  • Bausch Health
  • Allergan
  • Sebela Pharmaceuticals
  • Astellas Pharmaceuticals
  • Amneal Pharms
  • Pharscin Pharma

What are the factors driving applications of the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market?

  • Market segment by Type
  • XIFAXAN
  • Viberzi
  • Lotronex
  • Other
  • Market segment by Sales Channel
  • Hospitals Pharmacy
  • Retail Pharmacy
  • Other

The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Growth is anticipated to rise at a considerable rate during the forecast period, between 2021 and 2032. In 2021, the market was growing at a steady rate and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Which regions are leading the Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market?

North America (Covered in Chapter 6 and 13)

Europe (Covered in Chapter 7 and 13)

Asia-Pacific (Covered in Chapter 8 and 13)

Middle East and Africa (Covered in Chapter 9 and 13)

South America (Covered in Chapter 10 and 13)

Purchase this report (Price 3480 USD for a single-user license) – https://www.marketreportsworld.com/purchase/26323168

Detailed TOC of Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Research Report, 2025-2032

1 Market Overview
1.1 Product Overview and Scope of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Type: 2019 Versus 2025 Versus 2032
1.4 Market Analysis by Application
1.4.1 Overview: Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Application: 2019 Versus 2025 Versus 2032
1.5 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size & Forecast
1.5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2019 & 2025 & 2032)
1.5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity (2019-2032)
1.5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price (2019-2032)


2 Manufacturers Profiles


3 Competitive Environment: Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Manufacturer
3.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Manufacturer (2019-2025)
3.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Revenue by Manufacturer (2019-2025)
3.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Manufacturer (2019-2025)
3.4 Market Share Analysis (2025)
3.4.1 Producer Shipments of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
3.4.2 Top 3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer Market Share in 2025
3.4.2 Top 6 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Manufacturer Market Share in 2025
3.5 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Overall Company Footprint Analysis
3.5.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Region Footprint
3.5.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Company Product Type Footprint
3.5.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisitions, Agreements, and Collaborations


4 Consumption Analysis by Region
4.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region
4.1.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Region (2019-2032)
4.1.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Region (2019-2032)
4.1.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Region (2019-2032)
4.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2019-2032)
4.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2019-2032)
4.4 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2019-2032)
4.5 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2019-2032)
4.6 Middle East and Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value (2019-2032)


5 Market Segment by Type
5.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2019-2032)
5.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Type (2019-2032)
5.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Type (2019-2032)


6 Market Segment by Application
6.1 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Application (2019-2032)
6.2 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Application (2019-2032)
6.3 Global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Average Price by Application (2019-2032)


7 North America
7.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2019-2032)
7.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Application (2019-2032)
7.3 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
7.3.1 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2019-2032)
7.3.2 North America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2019-2032)
7.3.3 United States Market Size and Forecast (2019-2032)
7.3.4 Canada Market Size and Forecast (2019-2032)
7.3.5 Mexico Market Size and Forecast (2019-2032)


8 Europe
8.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2019-2032)
8.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Application (2019-2032)
8.3 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
8.3.1 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2019-2032)
8.3.2 Europe Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2019-2032)
8.3.3 Germany Market Size and Forecast (2019-2032)
8.3.4 France Market Size and Forecast (2019-2032)
8.3.5 United Kingdom Market Size and Forecast (2019-2032)
8.3.6 Russia Market Size and Forecast (2019-2032)
8.3.7 Italy Market Size and Forecast (2019-2032)


9 Asia-Pacific
9.1 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2019-2032)
9.2 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Application (2019-2032)
9.3 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Region
9.3.1 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Region (2019-2032)
9.3.2 Asia-Pacific Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Region (2019-2032)
9.3.3 China Market Size and Forecast (2019-2032)
9.3.4 Japan Market Size and Forecast (2019-2032)
9.3.5 Korea Market Size and Forecast (2019-2032)
9.3.6 India Market Size and Forecast (2019-2032)
9.3.7 Southeast Asia Market Size and Forecast (2019-2032)
9.3.8 Australia Market Size and Forecast (2019-2032)


10 South America
10.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2019-2032)
10.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Application (2019-2032)
10.3 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
10.3.1 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2019-2032)
10.3.2 South America Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2019-2032)
10.3.3 Brazil Market Size and Forecast (2019-2032)
10.3.4 Argentina Market Size and Forecast (2019-2032)


11 Middle East & Africa
11.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Type (2019-2032)
11.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Application (2019-2032)
11.3 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Size by Country
11.3.1 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Sales Quantity by Country (2019-2032)
11.3.2 Middle East & Africa Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Consumption Value by Country (2019-2032)
11.3.3 Turkey Market Size and Forecast (2019-2032)
11.3.4 Egypt Market Size and Forecast (2019-2032)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2032)
11.3.6 South Africa Market Size and Forecast (2019-2032)


12 Market Dynamics
12.1 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Drivers
12.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Market Restraints
12.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry


13 Raw Material and Industry Chain
13.1 Raw Material of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs and Key Manufacturers
13.2 Manufacturing Costs Percentage of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs
13.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Production Process
13.4 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Industrial Chain


14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Typical Distributors
14.3 Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs Typical Customers


15 Research Findings and Conclusion


16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Continued

About Us: –

Market Reports World is the Credible Source for Gaining the Market Reports that will Provide you with the Lead Your Business Needs. Market is changing rapidly with the ongoing expansion of the industry. Advancement in the technology has provided today’s businesses with multifaceted advantages resulting in daily economic shifts. Thus, it is very important for a company to comprehend the patterns of the market movements in order to strategize better. An efficient strategy offers the companies with a head start in planning and an edge over the competitors.

Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact [email protected]